Related Experiment Video
Updated: May 17, 2026
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Tumor-associated mutations in O⁶ -methylguanine DNA-methyltransferase (MGMT) reduce DNA repair functionality
Kristy L Lamb1, Yanfeng Liu, Kimiko Ishiguro
1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut; Department of Genetics, Yale University School of Medicine, New Haven, Connecticut.
Abstract:
MGMT is the primary vehicle for cellular removal of alkyl lesions from the O-6 position of guanine and the O-4 position of thymine. While key to the maintenance of genomic integrity, MGMT also removes damage induced by alkylating chemotherapies, inhibiting the efficacy of cancer treatment. Germline variants of human MGMT are well-characterized, but somatic variants found in tumors were, prior to this work, uncharacterized. We found that MGMT G132R, from a human esophageal tumor, and MGMT G156C, from a human colorectal cancer cell line, are unable to rescue methyltransferase-deficient Escherichia coli as well as wild type (WT) human MGMT after treatment with a methylating agent. Using pre-steady state kinetics, we biochemically characterized these variants as having a reduced rate constant. G132R binds DNA containing an O⁶ -methylguanine lesion half as tightly as WT MGMT, while G156C has a 40-fold decrease in binding affinity for the same damaged DNA versus WT. Mammalian cells expressing either G132R or G156C are more sensitive to methylating agents than mammalian cells expressing WT MGMT. G132R is slightly resistant to O⁶ -benzylguanine, an inhibitor of MGMT in clinical trials, while G156C is almost completely resistant to this inhibitor. The impared functionality of expressed variants G132R and G156C suggests that the presence of somatic variants of MGMT in a tumor could impact chemotherapeutic outcomes.
Insights
New research characterizes MGMT G132R and G156C variants found in tumors. These somatic variants show reduced DNA repair capacity, impacting cancer chemotherapy efficacy and drug resistance.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- O-6-alkylguanine DNA alkyltransferase (MGMT) repairs DNA damage but also counteracts alkylating chemotherapies.
- Somatic variants of MGMT in tumors are uncharacterized, potentially affecting treatment outcomes.
Purpose of the Study:
- To biochemically characterize two somatic MGMT variants (G132R and G156C) found in human tumors.
- To assess the functional impact of these variants on DNA repair and sensitivity to methylating agents and inhibitors.
Main Methods:
- Functional assays in methyltransferase-deficient E. coli.
- Pre-steady state kinetics to determine rate constants.
- DNA binding affinity measurements for O⁶-methylguanine lesions.
- Mammalian cell sensitivity assays to methylating agents and O⁶-benzylguanine.
Main Results:
- MGMT G132R and G156C variants exhibit reduced repair rates compared to wild-type (WT) MGMT.
- G132R shows decreased binding affinity for O⁶-methylguanine DNA, while G156C has a significantly lower affinity.
- Cells expressing G132R or G156C are more sensitive to methylating agents and show altered resistance to the MGMT inhibitor O⁶-benzylguanine.
Conclusions:
- Somatic MGMT variants G132R and G156C have impaired DNA repair functionality.
- These functional impairments suggest that tumor-specific MGMT variants could influence the effectiveness of alkylating chemotherapies.
- Understanding somatic MGMT variants is crucial for predicting patient response to cancer treatment.
More Related Videos
12:15Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
Published on: May 29, 2019
14:27Steady-state, Pre-steady-state, and Single-turnover Kinetic Measurement for DNA Glycosylase Activity
Published on: August 19, 2013
Related Concept Videos
01:20Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
01:36Mismatch Repair
01:36Mismatch Repair
01:38Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
01:08Nucleotide Excision Repair
01:08Nucleotide Excision Repair